Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Porter

Showing results (131-140 of 199) with videos related to

Pageof 20
Sort By:
Journal of Hematology & Oncology|April 21, 2024
Efficacy and safety of bendamustine for lymphodepletion before lisocabtagene maraleucelGuido Ghilardi, Luca Paruzzo, Vrutti Patel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2020
Long-Term Outcomes From a Randomized Dose Optimization Study of Chimeric Antigen Receptor Modified T Cells in Relapsed Chronic Lymphocytic LeukemiaNoelle V Frey, Saar Gill, Elizabeth O Hexner, et al.
American Journal of Hematology|April 4, 2020
Risk of invasive fungal infections in patients with high-risk MDS and AML receiving hypomethylating agentsGee Youn Geeny Kim, Jonathan Burns, Craig W Freyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2015
High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection in Allogeneic Stem-Cell Transplantation With Reduced-Intensity ConditioningRan Reshef, Austin P Huffman, Amy Gao, et al.
Journal of Vascular and Interventional Radiology : JVIR|January 8, 2004
Do simultaneous bilateral tunneled infusion catheters in patients undergoing bone marrow transplantation increase catheter-related complications?Lauren J Kaufman, Timothy W I Clark, David A Roberts, et al.
Blood|June 22, 2018
Nonviral RNA chimeric antigen receptor-modified T cells in patients with Hodgkin lymphomaJakub Svoboda, Susan R Rheingold, Saar I Gill, et al.
Transplantation and Cellular Therapy|July 19, 2022
Patterns of Use, Outcomes, and Resource Utilization among Recipients of Commercial Axicabtagene Ciloleucel and Tisagenlecleucel for Relapsed/Refractory Aggressive B Cell LymphomasPeter A Riedell, Wei-Ting Hwang, Loretta J Nastoupil, et al.
Blood|May 12, 2019
Chronic lymphocytic leukemia cells impair mitochondrial fitness in CD8<sup>+</sup> T cells and impede CAR T-cell efficacyJaco A C van Bruggen, Anne W J Martens, Joseph A Fraietta, et al.
Transplantation and Cellular Therapy|April 29, 2023
Patient Characteristics and Outcomes of Outpatient Tisagenlecleucel Recipients for B Cell Non-Hodgkin LymphomaNausheen Ahmed, William Wesson, Muhammad Umair Mushtaq, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2019
Optimizing Chimeric Antigen Receptor T-Cell Therapy for Adults With Acute Lymphoblastic LeukemiaNoelle V Frey, Pamela A Shaw, Elizabeth O Hexner, et al.
Pageof 20

Showing results (131-140 of 199) with videos related to

Sort By:
Pageof 20
Journal of Hematology & Oncology|April 21, 2024
Efficacy and safety of bendamustine for lymphodepletion before lisocabtagene maraleucelGuido Ghilardi, Luca Paruzzo, Vrutti Patel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2020
Long-Term Outcomes From a Randomized Dose Optimization Study of Chimeric Antigen Receptor Modified T Cells in Relapsed Chronic Lymphocytic LeukemiaNoelle V Frey, Saar Gill, Elizabeth O Hexner, et al.
American Journal of Hematology|April 4, 2020
Risk of invasive fungal infections in patients with high-risk MDS and AML receiving hypomethylating agentsGee Youn Geeny Kim, Jonathan Burns, Craig W Freyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2015
High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection in Allogeneic Stem-Cell Transplantation With Reduced-Intensity ConditioningRan Reshef, Austin P Huffman, Amy Gao, et al.
Journal of Vascular and Interventional Radiology : JVIR|January 8, 2004
Do simultaneous bilateral tunneled infusion catheters in patients undergoing bone marrow transplantation increase catheter-related complications?Lauren J Kaufman, Timothy W I Clark, David A Roberts, et al.
Blood|June 22, 2018
Nonviral RNA chimeric antigen receptor-modified T cells in patients with Hodgkin lymphomaJakub Svoboda, Susan R Rheingold, Saar I Gill, et al.
Transplantation and Cellular Therapy|July 19, 2022
Patterns of Use, Outcomes, and Resource Utilization among Recipients of Commercial Axicabtagene Ciloleucel and Tisagenlecleucel for Relapsed/Refractory Aggressive B Cell LymphomasPeter A Riedell, Wei-Ting Hwang, Loretta J Nastoupil, et al.
Blood|May 12, 2019
Chronic lymphocytic leukemia cells impair mitochondrial fitness in CD8<sup>+</sup> T cells and impede CAR T-cell efficacyJaco A C van Bruggen, Anne W J Martens, Joseph A Fraietta, et al.
Transplantation and Cellular Therapy|April 29, 2023
Patient Characteristics and Outcomes of Outpatient Tisagenlecleucel Recipients for B Cell Non-Hodgkin LymphomaNausheen Ahmed, William Wesson, Muhammad Umair Mushtaq, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2019
Optimizing Chimeric Antigen Receptor T-Cell Therapy for Adults With Acute Lymphoblastic LeukemiaNoelle V Frey, Pamela A Shaw, Elizabeth O Hexner, et al.
Pageof 20